Based in the corporate hamlet of Wilmington, Delaware, Incyte Corporation is uninhibited about its passion for inhibitors. The biotech firm, once known as Incyte Genomics, now concentrates on discovering and developing novel small molecule drugs to treat serious unmet medical needs. The firm's pipeline includes programs for HIV, cancer, diabetes and inflammatory diseases such as rheumatoid arthritis, multiple sclerosis and asthma. It has shifted its focus from its former practice of offering access to its genomic database and patent library. ......

	Read more of the Incyte Basic Snapshot
	Read the extended Gold Snapshot for Incyte, with 3x the info of the basic snapshot.